Advertisement
American Journal of Kidney Diseases

Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons

Published:February 06, 2015DOI:https://doi.org/10.1053/j.ajkd.2014.12.014

      Background

      Since the bundled end-stage renal disease prospective payment system began in 2011 in the United States, some hemodialysis practices have changed substantially, raising the question of whether vascular access practice also has changed. We describe monthly US vascular access use from August 2010 to August 2013 with international comparisons, and other aspects of US vascular access practice.

      Study Design

      Prospective observational cohort study of vascular access.

      Setting & Participants

      Maintenance hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor (DPM) in the United States (N = 3,442; US patients) and 19 other nations (N = 8,478).

      Predictors

      Country, patient demographics, time period.

      Outcomes

      Vascular access use, pre–end-stage renal disease access timing of first nephrologist care and arteriovenous access placement, patient self-reported vascular access preferences (United States only), treatment practices as stated by medical directors.

      Results

      In the United States from August 2010 to August 2013, arteriovenous fistula (AVF) use increased from 63% to 68%, while catheter use declined from 19% to 15%. Although AVF use did not differ greatly across age groups, arteriovenous graft use was 2-fold higher among black (26%) versus nonblack US patients (13%) in 2013. Across 20 countries in 2013, AVF use ranged from 49% to 92%, whereas catheter use ranged from 1% to 45%. Patient-reported vascular access preferences differed by sex and race, with 16% to 20% of patients feeling uninformed regarding benefits/risks of different vascular access types. Among new (incident) US hemodialysis patients, AVF use remains low, with ∼70% initiating hemodialysis therapy with a catheter (60% starting with catheter when having ≥4 months of predialysis nephrology care). In the United States, longer typical times to first AVF cannulation were reported.

      Limitations

      Noncompletion of surveys may affect the generalizability of findings to the wider hemodialysis population.

      Conclusions

      AVF use has increased, with catheter use decreasing among prevalent US hemodialysis patients since the introduction of the prospective payment system. However, AVF use at dialysis therapy initiation remains low, suggesting that reforms affecting predialysis care may be necessary to incentivize improvements in fistula rates at dialysis therapy initiation as achieved for prevalent hemodialysis patients.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pisoni R.L.
        • Arrington C.J.
        • Albert J.M.
        • et al.
        Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.
        Am J Kidney Dis. 2009; 53: 475-491
        • Polkinghorne K.R.
        • McDonald S.P.
        • Atkins R.C.
        • Kerr P.G.
        Vascular access and all-cause mortality: a propensity score analysis.
        J Am Soc Nephrol. 2004; 15: 477-486
        • Allon M.
        • Daugirdas J.
        • Depner T.A.
        • Greene T.
        • Ornt D.
        • Schwab S.J.
        Effect of change in vascular access on patient mortality in hemodialysis patients.
        Am J Kidney Dis. 2006; 47: 469-477
        • Lacson Jr., E.
        • Wang W.
        • Hakim R.M.
        • Teng M.
        • Lazarus J.M.
        Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
        Am J Kidney Dis. 2009; 53: 79-90
        • Lok C.E.
        • Foley R.
        Vascular access morbidity and mortality: trends of the last decade.
        Clin J Am Soc Nephrol. 2013; 8: 1213-1219
        • Lacson Jr., E.
        • Wang W.
        • Lazarus J.M.
        • Hakim R.M.
        Change in vascular access and mortality in maintenance hemodialysis patients.
        Am J Kidney Dis. 2009; 54: 912-921
        • Bradbury B.D.
        • Chen F.
        • Furniss A.
        • et al.
        Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.
        Am J Kidney Dis. 2009; 53: 804-814
        • Xue H.
        • Ix J.H.
        • Wang W.
        • et al.
        Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications.
        Am J Kidney Dis. 2013; 61: 123-130
        • Astor B.C.
        • Eustace J.A.
        • Powe N.R.
        • et al.
        CHOICE Study: type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
        J Am Soc Nephrol. 2005; 16: 1449-1455
        • Chan K.E.
        • Maddux F.W.
        • Tolkoff-Rubin N.
        • Karumanchi S.A.
        • Thadhani R.
        • Hakim R.M.
        Early outcomes among those initiating chronic dialysis in the United States.
        Clin J Am Soc Nephrol. 2011; 6: 2642-2649
        • Ng L.J.
        • Chen F.
        • Pisoni R.L.
        • et al.
        Hospitalization risks related to vascular access type among incident US hemodialysis patients.
        Nephrol Dial Transplant. 2011; 26: 3659-3666
        • Ravani P.
        • Gillespie B.W.
        • Quinn R.R.
        • et al.
        Temporal risk profile for infectious and noninfectious complications of hemodialysis access.
        J Am Soc Nephrol. 2013; 24: 1668-1677
        • Thomson P.C.
        • Stirling C.M.
        • Geddes C.C.
        • Morris S.T.
        • Mactier R.A.
        Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death.
        QJM. 2007; 100: 415-422
        • Patel P.R.
        • Yi S.H.
        • Booth S.
        • et al.
        Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report.
        Am J Kidney Dis. 2013; 62: 322-330
        • Ishani A.
        • Collins A.J.
        • Herzog C.A.
        • Foley R.N.
        Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 Study.
        Kidney Int. 2005; 68: 311-318
        • Hoen B.
        • Paul-Dauphin A.
        • Hestin D.
        • Kessler M.
        EPIBACDIAL: a multicenter retrospective study of risk factors for bacteremia in chronic hemodialysis patients.
        J Am Soc Nephrol. 1998; 9: 869-876
        • Powe N.R.
        • Jaar B.
        • Furth S.L.
        • Hermann J.
        • Briggs W.
        Septicemia in dialysis patients: incidence, risk factors, and prognosis.
        Kidney Int. 1999; 55: 1081-1090
        • George A.
        • Tokars J.I.
        • Clutterbuck E.J.
        • Bamford K.B.
        • Pusey C.
        • Holmes A.H.
        Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study.
        BMJ. 2006; 332: 1435
        • Inrig J.K.
        • Reed S.D.
        • Szczech L.A.
        • et al.
        Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
        Clin J Am Soc Nephrol. 2006; 1: 518-524
        • Jean G.
        • Charra B.
        • Chazot C.
        • et al.
        Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.
        Nephron. 2002; 91: 399-405
        • Kosa D.S.
        • Lok C.E.
        The economics of hemodialysis catheter-related infection prophylaxis.
        Semin Dial. 2013; 26: 482-493
        • Engemann J.J.
        • Friedman J.Y.
        • Reed S.D.
        • et al.
        Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.
        Infect Control Hosp Epidemiol. 2005; 26: 534-539
        • Ramanathan V.
        • Chiu E.J.
        • Thomas J.T.
        • Khan A.
        • Dolson G.M.
        • Darouiche R.O.
        Healthcare costs associated with hemodialysis catheter-related infections: a single-center experience.
        Infect Control Hosp Epidemiol. 2007; 28: 606-609
        • Lee H.
        • Manns B.
        • Taub K.
        • et al.
        Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
        Am J Kidney Dis. 2002; 40: 611-622
        • Xue H.
        • Lacson Jr., E.
        • Wang W.
        • Curhan G.C.
        • Brunelli S.M.
        Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis.
        Clin J Am Soc Nephrol. 2010; 5: 2289-2296
        • Solid C.A.
        • Carlin C.
        Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation.
        Am J Nephrol. 2012; 35: 498-508
      1. Fistula First Breakthrough Initiative: National Vascular Access Improvement Initiative. http://www.fistulafirst.org/. Accessed August 4, 2014.

      2. National Kidney Foundation. KDOQI 2006 vascular access guidelines. https://www.kidney.org/sites/default/files/docs/12-50-0210_jag_dcp_guidelines-va_oct06_sectionc_ofc.pdf. Accessed August 4, 2014.

      3. Fluck R, Kumwenda M. Clinical practice guidelines: vascular access for haemodialysis. 5th ed. UK Renal Association, 2008-2011. Final version (5.01.11). http://www.renal.org/docs/default-source/guidelines-resources/Vascular_Access_for_Haemodialysis_-_FINAL_VERSION_-_05_January_2011.pdf?sfvrsn=0. Accessed August 4, 2014.

        • Ohira S.
        • Naito H.
        • Amano I.
        • et al.
        2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis.
        Ther Apher Dial. 2006; 10: 449-462
        • Vassalotti J.A.
        • Jennings W.C.
        • Beathard G.A.
        • et al.
        Fistula First Breakthrough Initiative: targeting catheter last in fistula first.
        Semin Dial. 2012; 25: 303-310
        • Gomes A.
        • Schmidt R.
        • Wish J.
        Re-envisioning fistula first in a patient-centered culture.
        Clin J Am Soc Nephrol. 2013; 8: 1791-1797
        • Lok C.E.
        • Davidson I.
        Optimal choice of dialysis access for chronic kidney disease patients: developing a life plan for dialysis access.
        Semin Nephrol. 2012; 32: 530-537
        • Yan G.
        • Cheung A.K.
        • Ma J.Z.
        • et al.
        The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD.
        Clin J Am Soc Nephrol. 2013; 8: 610-618
        • Al-Jaishi A.A.
        • Oliver M.J.
        • Thomas S.M.
        • et al.
        Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis.
        Am J Kidney Dis. 2014; 63: 464-478
        • DeSilva R.N.
        • Patibandla B.K.
        • Vin Y.
        • et al.
        Fistula first is not always the best strategy for the elderly.
        J Am Soc Nephrol. 2013; 24: 1297-1304
        • Young E.W.
        • Goodkin D.A.
        • Mapes D.L.
        • et al.
        The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study.
        Kidney Int Suppl. 2000; 74: S74-S81
        • Pisoni R.L.
        • Gillespie B.W.
        • Dickinson D.M.
        • Chen K.
        • Kutner M.
        • Wolfe R.A.
        The Dialysis Outcomes and Practice Patterns Study: design, data elements, and methodology.
        Am J Kidney Dis. 2004; 44: S7-S15
        • Robinson B.
        • Fuller D.
        • Zinsser D.
        • et al.
        The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: rationale and methods for an initiative to monitor the new US bundled dialysis payment system.
        Am J Kidney Dis. 2011; 57: 822-831
        • Pisoni R.L.
        • Young E.W.
        • Dykstra D.M.
        • et al.
        Vascular access use in Europe and the United States: results from the DOPPS.
        Kidney Int. 2002; 61: 305-316
        • Lacson Jr., E.
        • Lazarus J.M.
        • Himmelfarb J.
        • Ikizler T.A.
        • Hakim R.M.
        Balancing fistula first with catheters last.
        Am J Kidney Dis. 2007; 50: 379-395
        • Ethier J.
        • Mendelssohn D.C.
        • Elder S.J.
        • et al.
        Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.
        Nephrol Dial Transplant. 2008; 23: 3219-3226
        • US Renal Data System
        2014 Annual Data Report: An Overview of the Epidemiology of Kidney Disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2014
        • Robinson B.
        • Zhang J.
        • Morgenstern H.
        • et al.
        Worldwide, mortality risk is high soon after initiation of hemodialysis.
        Kidney Int. 2014; 85: 158-165
        • Bradbury B.D.
        • Fissell R.B.
        • Albert J.M.
        • et al.
        Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Clin J Am Soc Nephrol. 2007; 2: 89-99
        • Allon M.
        • Dinwiddie L.
        • Lacson Jr., E.
        • et al.
        Medicare reimbursement policies and hemodialysis vascular access outcomes: a need for change.
        J Am Soc Nephrol. 2011; 22: 426-430
        • McClellan W.M.
        • Wasse H.
        • McClellan A.C.
        • Holt J.
        • Krisher J.
        • Waller L.A.
        Geographic concentration of poverty and arteriovenous fistula use among ESRD patients.
        J Am Soc Nephrol. 2010; 21: 1776-1782
        • Mollicone D.
        • Pulliam J.
        • Lacson Jr., E.
        The culture of education in a large dialysis organization: informing patient-centered decision making on treatment options for renal replacement therapy.
        Semin Dial. 2013; 26: 143-147
        • Davis J.S.
        • Zuber K.
        Implementing patient education in the CKD clinic.
        Adv Chronic Kidney Dis. 2013; 20: 320-325
        • Stehman-Breen C.O.
        • Sherrard D.J.
        • Gillen D.
        • Caps M.
        Determinants of type and timing of initial permanent hemodialysis vascular access.
        Kidney Int. 2000; 57: 639-645
        • O'Hare A.M.
        • Bertenthal D.
        • Walter L.C.
        • Garg A.X.
        • Covinsky K.
        • Kaufman J.S.
        When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration?.
        Kidney Int. 2007; 71: 555-561
        • Rosas S.E.
        • Feldman H.I.
        Synthetic hemodialysis access vs native arteriovenous fistula: a cost-utility analysis.
        Ann Surg. 2012; 255: 181-186
        • Saran R.
        • Elder S.J.
        • Goodkin D.A.
        • et al.
        Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study.
        Ann Surg. 2008; 247: 885-891
        • Ishaque B.
        • Zayed M.A.
        • Miller J.
        • et al.
        Ethnic differences in arm vein diameter and arteriovenous fistula creation rates in men undergoing hemodialysis access.
        J Vasc Surg. 2012; 56: 424-432
        • Caplin N.
        • Sedlacek M.
        • Teodorescu V.
        • Falk A.
        • Uribarri J.
        Venous access: women are equal.
        Am J Kidney Dis. 2003; 41: 429-432
        • Peterson W.J.
        • Barker J.
        • Allon M.
        Disparities in fistula maturation persist despite preoperative vascular mapping.
        Clin J Am Soc Nephrol. 2008; 3: 437-441
        • Fissell R.B.
        • Fuller D.S.
        • Morgenstern H.
        • et al.
        Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS.
        J Vasc Access. 2013; 14: 264-272
        • Rayner H.C.
        • Pisoni R.L.
        • Gillespie B.M.
        • et al.
        Creation, cannulation and survival of arterio-venous fistulae: data from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Kidney Int. 2003; 63: 323-330
        • Hod T.
        • Patibandla B.K.
        • Vin Y.
        • Brown R.S.
        • Goldfarb-Rumyantzev A.S.
        Arteriovenous fistula placement in the elderly: when is the optimal time?.
        J Am Soc Nephrol. 2015; 26: 448-456
        • Pisoni R.L.
        • Fuller D.
        • Bieber B.
        • et al.
        The DOPPS Practice Monitor for US dialysis care: trends through August 2011.
        Am J Kidney Dis. 2012; 60: 160-167